Vaccination News Home Page subscribe Vaccination NewsLetter
http://www.nytimes.com/2003/01/06/health/06RITA.html
HICAGO,
Jan. 5 (Reuters) — There is no convincing evidence that giving hyperactive
children stimulants like Ritalin leads to drug abuse later in life, researchers
reported today.
The finding confirms results from 11 previous studies, the researchers said, adding that they hoped it would dispel public concerns about the stimulants, which are chemically similar to cocaine.
|
|
|
|
"The present results indicate that clinicians probably need not fear that the stimulant treatment of children with attention-deficit/hyperactivity disorder is predisposing those children to later drug use, dependence or abuse," said the report, published in the January issue of Pediatrics, the journal of the American Academy of Pediatrics.
The study, at the University of Massachusetts Medical School and the Medical
College of Wisconsin, kept track of 147 hyperactive children for 13 years, into
adulthood. Some were treated with stimulants, primarily methylphenidate, the
ingredient in Ritalin, a brand sold by
The report concluded that there was no "consistent or convincing evidence that stimulant treatment in childhood or during adolescence was associated with risk for adolescent or adult substance use, the frequency of such use in adulthood or the likelihood of having a substance dependence or abuse disorder."
The study covered use of 10 legal and illegal drugs including alcohol, tobacco, heroin, marijuana, cocaine, hallucinogens and hashish.
In the United States attention deficit disorder is diagnosed in 3 percent to 5 percent of children. Symptoms are a reduced ability to concentrate, difficulty in organizing tasks and belongings and hyperactive, impulsive behavior.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.